Kotak Mahindra Bank: The bank's net profit rose to Rs 3,495.59 crore in Q4 FY23 as against Rs 2,767.40 crore posted in Q4 FY22. Total income rose to Rs 12,007.23 crore in Q4 FY23 from Rs 8,770.04 crore recorded in the corresponding quarter of previous year.
NTPC: NTPC has signed a Supplementary Joint Venture Agreement (SJVA) with Nuclear Power Corporation of India on 1 May 2023. This Supplementary Joint Venture Agreement (SJVA) will amend Joint Venture Agreement (JVA) dated 27 April 2010 and form integral part of JVA dated 27 April 2010.
UltraTech Cement: The cement major's consolidated net profit (from continuing operations) tumbled 31.48% to Rs 1,685.95 crore in Q4 FY23 as against Rs 2,460.51 crore posted in Q4 FY22. Revenue from operations grew by 18.36% to Rs 18,662.38 crore in Q4 FY23 from Rs 15,767.28 crore recorded in the corresponding quarter of previous year.
Maruti Suzuki India: Total sales stood at 160,529 units in April 2023 as compared to 150,661 units in April 2022. The shortage of electronic components had some impact on the production of vehicles. The company took all possible measures to minimise the impact.
Tata Motors: Sales in the domestic & international market for April 2023 stood at 69,599 vehicles, compared to 72,468 units during April 2022.
Hero MotoCorp: The company sold 396,107 units in April 2023 from 418,622 units sold in April 2022.
Biocon: The company's subsidiary Biocon Biologics' integrated, multi-product, monoclonal antibodies (mAbs) Drug Substance manufacturing facility (B3) at Biocon Park, Bengaluru, has received a Certificate of GMP Compliance. The certification is for an additional product, biosimilar Bevacizumab, from the representative European inspection authority, Health Products Regulatory Authority (HPRA), Ireland.
Powered by Capital Market - Live News